Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak L Bhatt

Showing results (931-940 of 1,708) with videos related to

Pageof 171
Sort By:
Cardiovascular Diabetology|March 13, 2025
Cardiometabolic risk factors and disease trends for atrial fibrillation in individuals with type 1 diabetes: a nationwide registry studyLara El Khalili, Linn El Khalili, Araz Rawshani, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 31, 2021
Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital PerspectiveIvar S Jensen, Elizabeth Wu, Philip L Cyr, et al.
Diabetes, Obesity & Metabolism|December 28, 2020
The cost-effectiveness of dapagliflozin in treating high-risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE-TIMI 58 trialPhil McEwan, Angharad R Morgan, Rebecca Boyce, et al.
Journal of the American Heart Association|October 18, 2014
Short- and long-term rehospitalization and mortality for heart failure in 4 racial/ethnic populationsRey P Vivo, Selim R Krim, Li Liang, et al.
Lancet (London, England)|September 21, 2022
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 TrialDeepak L Bhatt, Muthiah Vaduganathan, David E Kandzari, et al.
Journal of the American College of Cardiology|April 6, 2016
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54Deepak L Bhatt, Marc P Bonaca, Sameer Bansilal, et al.
Circulation. Cardiovascular Quality and Outcomes|April 2, 2020
Association of Outpatient Practice-Level Socioeconomic Disadvantage With Quality of Care and Outcomes Among Older Adults With Coronary Artery Disease: Implications for Value-Based PaymentRishi K Wadhera, Deepak L Bhatt, Amy J H Kind, et al.
European Heart Journal. Acute Cardiovascular Care|February 15, 2021
Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysisMohamed O Mohamed, Harriette G C Van Spall, Evangelos Kontopantelis, et al.
The New England Journal of Medicine|February 16, 2017
Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year OutcomesPhilip R Schauer, Deepak L Bhatt, John P Kirwan, et al.
Annals of the Rheumatic Diseases|January 4, 2023
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trialJeffrey R Curtis, Kunihiro Yamaoka, Yi-Hsing Chen, et al.
Pageof 171

Showing results (931-940 of 1,708) with videos related to

Sort By:
Pageof 171
Cardiovascular Diabetology|March 13, 2025
Cardiometabolic risk factors and disease trends for atrial fibrillation in individuals with type 1 diabetes: a nationwide registry studyLara El Khalili, Linn El Khalili, Araz Rawshani, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 31, 2021
Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital PerspectiveIvar S Jensen, Elizabeth Wu, Philip L Cyr, et al.
Diabetes, Obesity & Metabolism|December 28, 2020
The cost-effectiveness of dapagliflozin in treating high-risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE-TIMI 58 trialPhil McEwan, Angharad R Morgan, Rebecca Boyce, et al.
Journal of the American Heart Association|October 18, 2014
Short- and long-term rehospitalization and mortality for heart failure in 4 racial/ethnic populationsRey P Vivo, Selim R Krim, Li Liang, et al.
Lancet (London, England)|September 21, 2022
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 TrialDeepak L Bhatt, Muthiah Vaduganathan, David E Kandzari, et al.
Journal of the American College of Cardiology|April 6, 2016
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54Deepak L Bhatt, Marc P Bonaca, Sameer Bansilal, et al.
Circulation. Cardiovascular Quality and Outcomes|April 2, 2020
Association of Outpatient Practice-Level Socioeconomic Disadvantage With Quality of Care and Outcomes Among Older Adults With Coronary Artery Disease: Implications for Value-Based PaymentRishi K Wadhera, Deepak L Bhatt, Amy J H Kind, et al.
European Heart Journal. Acute Cardiovascular Care|February 15, 2021
Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysisMohamed O Mohamed, Harriette G C Van Spall, Evangelos Kontopantelis, et al.
The New England Journal of Medicine|February 16, 2017
Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year OutcomesPhilip R Schauer, Deepak L Bhatt, John P Kirwan, et al.
Annals of the Rheumatic Diseases|January 4, 2023
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trialJeffrey R Curtis, Kunihiro Yamaoka, Yi-Hsing Chen, et al.
Pageof 171